Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Labs

This article was originally published in The Gray Sheet

Executive Summary

Nov. 23-24 hearing is scheduled in Chicago federal court on plaintiff's motion for a preliminary injunction against Alza Corp. and Abbott Laboratories to block the proposed merger pending dissemination to Alza shareholders the facts concerning the status of Abbott's negotiations with FDA on manufacturing deficiencies at Abbott's Lake County, Illinois facilities, Abbott reports Oct. 28. Abbott announced continuing difficulties with FDA on Sept. 28 (1"The Gray Sheet" Oct. 4, p. 16), seven days after Alza shareholders approved the merger
Advertisement

Related Content

Abbott Facing FDA Consent Decree Over Alleged QSR Violations
Abbott Facing FDA Consent Decree Over Alleged QSR Violations
Advertisement
UsernamePublicRestriction

Register

MT012498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel